A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying.

New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially when it comes to detecting more cancers at earlier stages when treatment is ...

IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...

Prostate cancer risk factors include some that can’t be changed, such as having a family history of the disease and a genetic predisposition for developing the cancer ...

We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

When it comes to prostate cancer, there’s a lot of confusion and guesswork floating around—especially among men who don’t ...